Outlook Wealth Advisors, LLC Halozyme Therapeutics, Inc. Transaction History
Outlook Wealth Advisors, LLC
- $298 Million
- Q1 2025
A detailed history of Outlook Wealth Advisors, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Outlook Wealth Advisors, LLC holds 7,464 shares of HALO stock, worth $463,514. This represents 0.16% of its overall portfolio holdings.
Number of Shares
7,464
Previous 7,428
0.48%
Holding current value
$463,514
Previous $355,000
34.08%
% of portfolio
0.16%
Previous 0.12%
Shares
3 transactions
Others Institutions Holding HALO
# of Institutions
581Shares Held
123MCall Options Held
308KPut Options Held
186K-
Black Rock Inc. New York, NY17.6MShares$1.09 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$797 Million0.02% of portfolio
-
State Street Corp Boston, MA6.05MShares$376 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA3.89MShares$242 Million0.05% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.67MShares$228 Million5.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.65B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...